Stocktoria

HYPERION DEFI, INC. HYPD

Nasdaq · XNAS · stock · Pharmaceutical Preparations · website · IPO 2018-01-25
Chart by TradingView
5/9
Piotroski F — financial health
-16.62
Altman Z″ — distress risk · distress
Dividend payout · no dividend

Financials & ratios (annual, from 10-K)

MetricFY2025FY2024FY2023FY2022FY2021
Financials
Revenue$813,455$57,336$3,787$14.0M
Gross profit$510,165-$3.9M-$12,218$12.4M
Operating income-$46.7M-$48.7M-$25.4M-$26.9M-$13.0M
Net income-$45.3M-$49.8M-$27.3M-$28.0M-$12.8M
Operating cash flow-$14.8M-$30.1M-$23.8M-$25.1M-$20.9M
Free cash flow-$30.3M-$26.7M-$25.6M-$22.1M
Total assets$51.8M$3.7M$28.8M$31.0M$31.7M
Total liabilities$10.7M$16.8M$19.8M$13.8M$11.2M
Shareholders' equity$41.1M-$13.1M$9.0M$17.2M$20.5M
Ratios
Gross margin62.7%-6749.5%-322.6%88.6%
Operating margin-5743.5%-85004.6%-670885.8%-93.0%
Net margin-5570.6%-86888.6%-719859.9%-91.3%
FCF margin-52815.8%-704624.5%-157.9%
Return on assets-87.5%-1358.3%-94.7%-90.3%-40.4%
Return on equity-110.4%380.4%-302.9%-162.5%-62.4%
Current ratio2.680.172.176.131.97
Revenue growth1318.8%1414.0%600.0%

Notable holders (13F)

InvestorSharesValue
RENAISSANCE TECHNOLOGIES LLC115,641$398,961

Why these scores methodology →

Piotroski F-score: 5/9

  • Positive return on assets
  • Positive operating cash flow
  • Rising ROA
  • Cash flow exceeds net income
  • Lower long-term debt
  • Rising current ratio
  • No share dilution
  • Rising gross margin
  • Rising asset turnover

Altman Z″: -16.62 (distress)

  • Working capital / assets 0.088
  • Retained earnings / assets -4.648
  • EBIT / assets -0.903
  • Equity / liabilities 3.836

Sector peers

VFS · TM · HMC · SONY · AAPL · XOM · all Manufacturing →

Source: SEC EDGAR filings · CIK 0001682639 · as of 2025-12-31. Figures are facts from filings plus Stocktoria's own computed scores — not investment advice.